Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer.

Cancer research communications·2026
Same author

Explainable Machine Learning for Early Detection of Mild Cognitive Impairment, Fall Risk, and Frailty Using Sensor-Based Motor Function Data.

medRxiv : the preprint server for health sciences·2026
Same author

Tumor CTR1 and serum copper dynamics reveal a coordinated copper axis linked to high-grade triple-negative breast cancer biology.

medRxiv : the preprint server for health sciences·2026
Same author

Impact of Tumor Location on Predicting Early-Stage Breast Cancer Patient Survivability Using Explainable Machine Learning Models.

JCO clinical cancer informatics·2025
Same journal

Predicting Overall Survival in Patients With Multiple Primary Lung Cancer: Nomogram Development and Validation Study.

JMIR cancer·2026
Same journal

Large Language Models for Breast and Cervical Cancers Communication: Mixed Methods Evaluation Study Assessing Linguistic Quality, Safety, and Accessibility.

JMIR cancer·2026
Same journal

Multi-Turn LLM-Based Conversational Agents for Patients with Cancer and Caregivers: A Scoping Review.

JMIR cancer·2026
Same journal

Digital Intervention for Electronic Patient-Reported Outcomes in Advanced Cancer: Mixed Methods Study.

JMIR cancer·2026
Same journal

Online Intervention on Lung Cancer Screening Among High-Risk Individuals: Pilot Intervention Study.

JMIR cancer·2026
Same journal

Patient-Reported Outcomes on Quality of Life and Psychological Distress After Focal High-Intensity Focused Ultrasound for Prostate Cancer: Prospective Multicenter Study.

JMIR cancer·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

15.2K

Explainable AI for Predicting Mortality Risk in Metastatic Cancer: Retrospective Cohort Study Using the Memorial

Polycarp Nalela1, Deepthi Rao1, Praveen Rao1

  • 1The University of Missouri, Columbia, MO, United States.

JMIR Cancer
|January 13, 2026
PubMed
Summary
This summary is machine-generated.

Explainable machine learning models accurately predict survival in metastatic cancer patients, identifying key prognostic factors like metastasis site count and tumor mutational burden for improved risk stratification.

Keywords:
explainable artificial intelligencemachine learning in oncologymetastatic cancersurvivability prediction

More Related Videos

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis
07:47

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis

Published on: June 26, 2016

10.2K
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.4K

Related Experiment Videos

Last Updated: Jun 19, 2026

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

15.2K
Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis
07:47

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis

Published on: June 26, 2016

10.2K
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.4K

Area of Science:

  • Computational biology and bioinformatics
  • Oncology and cancer research
  • Machine learning and artificial intelligence

Background:

  • Metastatic cancer is a leading cause of cancer mortality, with limited survival prediction due to clinical heterogeneity and complex molecular features.
  • Machine learning (ML) offers a powerful approach to integrate diverse patient and tumor data for enhanced risk stratification and precision oncology.
  • Real-world data and advanced ML techniques are crucial for developing explainable predictive models in oncology.

Purpose of the Study:

  • To develop and interpret ML models for predicting overall survival in patients with metastatic cancer using the MSK-MET dataset.
  • To identify key prognostic biomarkers for metastatic cancer through explainable artificial intelligence (AI) techniques.
  • To leverage ML for improved patient counseling, treatment planning, and precision oncology workflows.

Main Methods:

  • Retrospective analysis of the Memorial Sloan Kettering-Metastatic (MSK-MET) cohort (n=20,338) across 27 tumor types.
  • Trained five ML classifiers (XGBoost, logistic regression, random forest, decision tree, naive Bayes) using stratified data splits and cross-validation.
  • Assessed model performance using accuracy, AUC, precision, recall, F1-score; employed SHAP for explainability and XGBoost-Cox for time-to-event prediction.

Main Results:

  • Extreme gradient boosting (XGBoost) demonstrated superior performance (accuracy=0.74, AUC=0.82) compared to other classifiers.
  • The XGBoost-Cox model (C-index=0.70) outperformed traditional Cox models (C-index=0.66) in survival analysis.
  • SHAP and Cox models identified metastatic site count, tumor mutational burden, and distant liver/bone metastases as strong prognostic factors.

Conclusions:

  • Explainable ML models, particularly XGBoost with SHAP, effectively predict survivability in metastatic cancers and highlight clinically meaningful features.
  • These ML tools can aid patient counseling, treatment planning, and integration into precision oncology.
  • Future research should focus on external validation, EHR integration, and prospective clinical evaluation.